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Adrenal insufficiency is a potentially life-threatening condition when it occurs acutely, as in adrenal hemorrhage. Generally it is not
reversible and requires chronic replacement therapy. Acute intermittent porphyria (AIP) is a rare genetic disease characterized by
alterations in heme biosynthesis that result in accumulation of precursors in tissues. A crisis can be triggered by many conditions
such as surgery and infections. Symptoms are similar to those of acute hypoadrenalism.Moreover, both conditions are characterized
by hyponatremia. We describe the case of a postmenopausal woman known to be affected by AIP who developed after surgery a
primary adrenal insufficiency associated with adrenal enlargement; the latter completely reverted in six months.
1. Introduction
Adrenal insufficiency is an infrequent endocrine disorder
mostly due to autoimmune adrenalitis; less common causes
are infections, trauma, and metastatic cancer. Adrenal insuf-
ficiency is a potentially life-threatening conditionwhen acute,
as in adrenal hemorrhage, necrosis or thrombosis. Gener-
ally, adrenal damage is not reversible and requires chronic
replacement therapy.
Transient adrenal insufficiency has been described as
a manifestation of viral, parasitic, or mycotic infection, in
particular in premature newborn infants or immunocompro-
mised patients.
Acute intermittent porphyria (AIP) is a rare genetic
disease characterized by alterations in heme biosynthesis
which result in the accumulation of precursors in tissues.
An AIP crisis can be triggered by many conditions such
as surgery, infections, fasting, and the use of many drugs
including anesthetics.The symptoms of a crisis are abdominal
pain, nausea, and vomiting, similar to those of acute hypoa-
drenalism. Both conditions are also characterized by the
development of hyponatremia and, in biochemically active
AIP, cortisol levels have been reported to be reduced; thus the
diagnosis may be challenging.
We describe the case of a postmenopausal woman known
to be affected by AIP who after surgery developed a primary
adrenal insufficiency associated with adrenal enlargement,
which completely reverted in six months. She was initially
treated with replacement therapy which was subsequently
reduced in dose, obtaining basal adrenocorticotrophic hor-
mone (ACTH) and cortisol normalization, whilemaintaining
an inadequate cortisol response to the ACTH test.
2. Case Presentation
A 65-year-old woman was referred to the intensive care unit
under suspicion of a postoperative AIP crisis.
She had a history of previous surgery for breast fibroade-
noma and was chronically affected by colonic diverticu-
losis, chronic gastritis, hypertension, and mild depressive
syndrome. She was treated with a proton-pump inhibitor,
metoprolol, enalapril, acetylsalicylic acid, and trazodone.
Porphyria had been diagnosed one year previously, after
demonstration of porphobilinogen and aminolevulinic acid
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Figure 1: AbdomenCT showing bilateral adrenal enlargement, highlighted by red arrows, with a hyperdense central area of 2 cmofmaximum
diameter (HU 25–35) in right adrenal gland.
Table 1: Biochemical data nine days after hip replacement.
Reference values
RBC (×106/uL) 2.96 4.2–5.4
Hb (g/dL) 9.0 12.0–16.0
MCV (fl) 88.9 77–94
PLT (×103/uL) 150 150–400
aPTT (sec.) 47.2 25–40
CRP (mg/L) 215 <10
PCT (ng/mL) 0.305 <0.046
Na (mmol/L) 132.6 137–145
K (mmol/L) 3.0 3.6–5.0
increase during an episode of abdominal pain, vomiting,
and hyponatremia. During the same hospitalization, because
of the onset of chest pain, ECG alterations, and troponin
increase, the patient underwent a coronary angiography
which was negative for stenosis. Thus takotsubo, a stress
cardiomyopathy simulating an acute coronary syndrome, was
diagnosed. In this critical care context, an ACTH and cortisol
assay were performed, resulting in 4.0 pM/L (n.v. 2–14) and
998.8 nM/L (n.v. 165.5–507.7), respectively.
Nine days after a right hip replacement surgery due to
severe arthrosis, the patient developed nausea and vomiting,
abdominal pain with paralytic ileus, urinary retention, and
upper limb paresthesia.
Laboratory analysis (see Table 1) showed normochromic
anemia, a platelet count in the lower range, prolonged partial
thromboplastin time, elevated C-reactive protein and procal-
citonin, hypokalemia, and hyponatremia. Thus, considering
the symptoms, an acute AIP crisis was suspected.
A chest X-ray was taken, which showed focal pneumonia
with bilateral pleural effusion.
The patient started treatment for AIP with hemin and
glucose solution, in addition to antibiotic treatment.
Due to the persistence of severe hyponatremia
(123.8mmol/L) and symptoms such as asthenia and nausea
19 days later, hypoadrenalism was suspected. The ACTH was
43 pM/L and cortisol 163.3 nM/L (data confirmed by a second
sample) with PRA 0.3 𝜇g/L/h (normal values: 0,60–4,18; RIA
Immunotech Beckman Coulter), aldosterone 47.2 pmol/L
(normal values: 48,3–270,0; RIA Immunotech Beckman
Coulter), and DHEA-S < 0.4 umol/L (CLIA, Centaur XPT,
Siemens). The patient was treated with no drug interfering
with adrenal function. The ACTH test 250𝜇g iv showed no
response of cortisol (see Table 2).
An abdominal computed tomography (CT) showed bilat-
eral adrenal enlargement, with a hyperdense central area of
2 cm maximum diameter (HU 25–35) in the right adrenal
gland (Figure 1). No suspicious lesion was identified.
Anti-adrenal antibodies were undetectable, as were anti-
cardiolipin antibodies.
A tuberculin test was negative and so were tests on can-
dida and aspergillus antigens. CMV DNA was undetectable.
Anti-HIV and anti-treponema antibodies were also negative.
Other mycosis infections (cryptococcosis, histoplasmosis,
and coccidioidomycosis) and parasitoses (trypanosomiasis)
were ruled out through appropriate serological tests.
The patient was initially treated with oral cortisone
acetate, 25mg in the morning and 12.5mg in the afternoon,
with rapid improvement of symptoms and normalization of
sodium levels. The patient was then discharged on glucocor-
ticoid replacement therapy (cortisone acetate 12.5mg twice
a day). Diagnosis of primary hypoadrenalism of uncertain
etiology associated with bilateral adrenal enlargement was
confirmed.
Three months later, the basal cortisol was 149.0 nM/L
which did not increase (see Table 2) after the ACTH test
(24 h after cortisone acetate withdrawal). Basal ACTH was
71 pM/L, PRA 1.0𝜇g/L/h, aldosterone 322.2 pmol/L, and
DHEA-S < 0.4 umol/L.
In a CT repeated 6months later, adrenal glands presented
with normalized volume (Figure 2), and, in particular, the
right lesion was no longer detected.
One year later, after gradual reduction in the dose of
cortisone acetate (6.25mg twice a day and then 6.25mg
once a day), ACTH and basal cortisol had normalized (see
Table 2). However the cortisol remained nonresponsive after
ACTH,with PRAand aldosterone always normal andDHEA-
S unchanged.
At present (30 months after diagnosis) the patient is
continuing a minimal dose of cortisone acetate (6.25mg
once a day) without symptoms. The last ACTH was 18 pM/L
with normal PRA and aldosterone. Cortisol basal levels
remain in the normal range and are progressively increasing
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Table 2: Adrenal function before hip replacement and during follow-up.
Time with respect to hip replacement
One year
before 19 days after 21 days after
3 months
after
12 months
after
30 months
after
ACTH (pM/L) n.v. 2–14 4 43 71 11 18
Basal cortisol (nM/L)
n.v. 165.5–507.7 998.8 163.3 278.7 149.0 366.9 477.3
Cortisol 30󸀠 after ACTH
250 𝜇g iv 278.7 162.8 366.9 460.8
Cortisol 60󸀠 after ACTH
250 𝜇g iv 264.9 154.5 331.1 502.1
Figure 2: Abdomen CT showing adrenal glands normalized in
volume 6 months later.
(see Table 2), although there has still been no response of
the cortisol to the ACTH test. At CT examination the left
adrenal gland was of normal volume, while the right one
showed an apparent reduction in sizewith an inhomogeneous
structure.These recent data support the progressive recovery
of the glucocorticoid secretion, although with an incomplete
functional normalization. Subsequent follow-up will assess
whether the partial deficit is persistent or if definitive recov-
ery is possible.
3. Discussion
Adrenal insufficiency is a rare condition mostly due to
autoimmune disease but potentially developing after trauma,
infections, neoplastic infiltration, or vascular damage, which
generally requires chronic replacement therapy.
Transient adrenal insufficiency on the other hand is
infrequent and is reported in the literature in premature
newborn, in infective diseases, in survivors of critical illness
[1], or, rarely, following acute adrenal hemorrhage [2]. Such
a hemorrhage is a severe potentially life-threatening or even
lethal condition when massive and bilateral. The clinical
diagnosis is challenging. This is particularly the case in
critically ill patients, due to nonspecific symptoms and signs
such as abdominal pain, vomiting, fever, hypotension, and
altered conscious state. Moreover a limited adrenal hemor-
rhage may give nonspecific symptoms. Hemorrhage has been
described after surgery, such as cholecystectomy, total knee
arthroplasty, duodenopancreatectomy, and vertebral surgery,
in sepsis, and is rarely reported as a spontaneous event,
mostly in pregnancy and in particular conditions such as
polycythemia vera and antiphospholipid syndrome.
In our patient, who experienced an acute primary
hypoadrenalism with bilateral glandular enlargement, the
CT appearance and subsequent partial normalization of
the adrenal function could be consistent with a bilateral
congestion leading to a hemorrhage,more evident in the right
adrenal gland, which had presumably occurred 1-2 weeks
before the imaging.
The history of AIP delayed the diagnosis of hypoad-
renalism due to the development of symptoms suggesting a
postoperative crisis. This delay may explain the CT appear-
ance of the adrenals, which was not typical of a hemorrhage
[3], though the hyperdense central area could be due to the
outbreak where the greatest concentrations of hemoglobin
were localized.
In our patient adrenal insufficiency seems to be a con-
sequence of recent surgery, which can potentially induce
adrenal hemorrhage, by itself but in particular due to the
heparin treatment, which is routinely used in the postoper-
ative period. The cortisol increase which had been observed
during a critical stress condition (takotsubo cardiomyopathy)
presumably indicates normal adrenal function, at least one
year before. Autoimmune and infective hypoadrenalismwere
ruled out. Risk factors for adrenal hemorrhage were present
such as postsurgery heparin treatment (which could explain
the platelet count in the lower range and the prolonged partial
thromboplastin time) and the occurrence of septic condition,
which may have worsened the clinical status. Undetectable
anticardiolipin antibodies, which are the most sensitive in
diagnosing antiphospholipid syndrome [4], allow reasonably
excluding this cause of adrenal failure.
The hypothesis of transient adrenal insufficiency related
to a poor entity hemorrhage is consistent with the clinical
evolution of the patient who reverted to normal adrenal
CT presentation in 6 months and to almost normal basal
function in 12 months. However, the lack of cortisol response
to ACTH test suggests that cortisol secretion could not be
further stimulated and therefore that the adrenal functional
recovery was partial.
AIP patients present similar symptoms to those of acute
hypoadrenalism (abdominal pain, nausea, and vomiting)
thus resulting in a potential confounder for clinicians. To
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the best of our knowledge only two cases of acute hypoad-
renalism have been reported after hip replacement. The first
was subsequent to enoxaparin-induced thrombocytopenia
[5], and the second was in a 75-year-old woman treated
after surgery with dabigatran who underwent thrombolysis
for massive pulmonary embolism [6]. In both cases, adrenal
insufficiency was definitive.
Our case highlights howdifficult the differential diagnosis
is in AIP patients, in whom adrenal insufficiency can be
misdiagnosed because of similar manifestations. A cause-
effect relationship between AIP, major surgery, and hypoa-
drenalism is conceivable but it cannot be proved: these
conditions could be coincident even if independent.
However, acute hypoadrenalism represents a potential
life-threatening condition which needs to be taken into
account, especially when severe and persistent hyponatremia
is observed.
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